MADISON, Wis., Oct. 28, 2014 (GLOBE NEWSWIRE) — Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that the company will host a webcast and conference call to discuss its financial results for the third quarter ended September 30, 2014.
||Tuesday, November 11, 2014
||8 a.m. ET
||The live webcast can be accessed via the investor relations section of CDI’s website at www.cellulardynamics.com and will be archived there following the call for approximately one year.
||(877) 312-5886 (Domestic)
||(206) 453-2872 (International)
||Reference conference ID# 27208775
About Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. (CDI) is a leading developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications. CDI’s proprietary iCell® Operating System (iCell O/S) includes true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell® Products). CDI’s iCell O/S products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our iCell O/S products, among other purposes, for drug discovery and screening; to test the safety and efficacy of their small molecule and biologic drug candidates; for stem cell banking; and in the research and development of cellular therapeutics. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin–Madison. CDI’s facilities are located in Madison, Wisconsin, with a second facility in Novato, California. See www.cellulardynamics.com.
Senior Director Investor Relations & Corporate Communications
Cellular Dynamics International, Inc.
Gitanjali Jain Ogawa
The Trout Group, LLC
Source: Cellular Dynamics International, Inc.
News Provided by Acquire Media